intensive care medicine limited
intensive care medicine limited Company Information
Company Number
07665135
Next Accounts
Jan 2025
Industry
General medical practice activities
Directors
Shareholders
simon ashworth
ann ashworth
Group Structure
View All
Contact
Registered Address
unit 7, mulberry place, pinnell road, london, SE9 6AR
Website
ccforum.biomedcentral.comintensive care medicine limited Estimated Valuation
Pomanda estimates the enterprise value of INTENSIVE CARE MEDICINE LIMITED at £1.3m based on a Turnover of £3.2m and 0.42x industry multiple (adjusted for size and gross margin).
intensive care medicine limited Estimated Valuation
Pomanda estimates the enterprise value of INTENSIVE CARE MEDICINE LIMITED at £1.5m based on an EBITDA of £446.1k and a 3.38x industry multiple (adjusted for size and gross margin).
intensive care medicine limited Estimated Valuation
Pomanda estimates the enterprise value of INTENSIVE CARE MEDICINE LIMITED at £1.7m based on Net Assets of £629.3k and 2.73x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Intensive Care Medicine Limited Overview
Intensive Care Medicine Limited is a dissolved company that was located in london, SE9 6AR with a Companies House number of 07665135. It operated in the general medical practice activities sector, SIC Code 86210. Founded in June 2011, it's largest shareholder was simon ashworth with a 80% stake. The last turnover for Intensive Care Medicine Limited was estimated at £3.2m.
Upgrade for unlimited company reports & a free credit check
Intensive Care Medicine Limited Health Check
Pomanda's financial health check has awarded Intensive Care Medicine Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
4 Weak
Size
annual sales of £3.2m, make it larger than the average company (£915.7k)
- Intensive Care Medicine Limited
£915.7k - Industry AVG
Growth
3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (6.2%)
- Intensive Care Medicine Limited
6.2% - Industry AVG
Production
with a gross margin of 24.8%, this company has a higher cost of product (42.2%)
- Intensive Care Medicine Limited
42.2% - Industry AVG
Profitability
an operating margin of 10.8% make it more profitable than the average company (9%)
- Intensive Care Medicine Limited
9% - Industry AVG
Employees
with 21 employees, this is below the industry average (78)
- Intensive Care Medicine Limited
78 - Industry AVG
Pay Structure
on an average salary of £28.6k, the company has an equivalent pay structure (£28.6k)
- Intensive Care Medicine Limited
£28.6k - Industry AVG
Efficiency
resulting in sales per employee of £150.3k, this is more efficient (£76.4k)
- Intensive Care Medicine Limited
£76.4k - Industry AVG
Debtor Days
it gets paid by customers after 60 days, this is later than average (27 days)
- Intensive Care Medicine Limited
27 days - Industry AVG
Creditor Days
its suppliers are paid after 83 days, this is slower than average (30 days)
- Intensive Care Medicine Limited
30 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Intensive Care Medicine Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (37 weeks)
7 weeks - Intensive Care Medicine Limited
37 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 46.8%, this is a lower level of debt than the average (64.1%)
46.8% - Intensive Care Medicine Limited
64.1% - Industry AVG
INTENSIVE CARE MEDICINE LIMITED financials
Intensive Care Medicine Limited's latest turnover from March 2015 is estimated at £3.2 million and the company has net assets of £629.3 thousand. According to their latest financial statements, we estimate that Intensive Care Medicine Limited has 21 employees and maintains cash reserves of £76.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|
| Tangible Assets | 50,196 | 8,905 | 0 | 0 |
| Intangible Assets | 530,867 | 619,345 | 707,822 | 796,300 |
| Investments & Other | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 581,063 | 628,250 | 707,822 | 796,300 |
| Stock & work in progress | 0 | 0 | 0 | 0 |
| Trade Debtors | 526,008 | 412,583 | 364,635 | 342,788 |
| Group Debtors | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 |
| Cash | 76,359 | 254,161 | 60,442 | 101,458 |
| misc current assets | 0 | 0 | 0 | 0 |
| total current assets | 602,367 | 666,744 | 425,077 | 444,246 |
| total assets | 1,183,430 | 1,294,994 | 1,132,899 | 1,240,546 |
| Bank overdraft | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 |
| Trade Creditors | 544,091 | 935,622 | 851,104 | 994,685 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 |
| total current liabilities | 544,091 | 935,622 | 851,104 | 994,685 |
| loans | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 |
| provisions | 10,039 | 0 | 0 | 0 |
| total long term liabilities | 10,039 | 0 | 0 | 0 |
| total liabilities | 554,130 | 935,622 | 851,104 | 994,685 |
| net assets | 629,300 | 359,372 | 281,795 | 245,861 |
| total shareholders funds | 629,300 | 359,372 | 281,795 | 245,861 |
| Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | 16,733 | 2,969 | 0 | 0 |
| Amortisation | 88,478 | 88,477 | 88,478 | 88,478 |
| Tax | ||||
| Stock | 0 | 0 | 0 | 0 |
| Debtors | 113,425 | 47,948 | 21,847 | 342,788 |
| Creditors | -391,531 | 84,518 | -143,581 | 994,685 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 10,039 | 0 | 0 | 0 |
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 |
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | -177,802 | 193,719 | -41,016 | 101,458 |
| overdraft | 0 | 0 | 0 | 0 |
| change in cash | -177,802 | 193,719 | -41,016 | 101,458 |
intensive care medicine limited Credit Report and Business Information
Intensive Care Medicine Limited Competitor Analysis
Perform a competitor analysis for intensive care medicine limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other undefined companies, companies in SE9 area or any other competitors across 12 key performance metrics.
intensive care medicine limited Ownership
INTENSIVE CARE MEDICINE LIMITED group structure
Intensive Care Medicine Limited has no subsidiary companies.
Ultimate parent company
INTENSIVE CARE MEDICINE LIMITED
07665135
intensive care medicine limited directors
Intensive Care Medicine Limited currently has 1 director, Dr Simon Ashworth serving since Jun 2011.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Simon Ashworth | England | 58 years | Jun 2011 | - | Director |
P&L
March 2015turnover
3.2m
+2%
operating profit
340.9k
0%
gross margin
24.8%
-4.32%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2015net assets
629.3k
+0.75%
total assets
1.2m
-0.09%
cash
76.4k
-0.7%
net assets
Total assets minus all liabilities
intensive care medicine limited company details
company number
07665135
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
June 2011
age
14
incorporated
UK
ultimate parent company
accounts
Total Exemption Small
last accounts submitted
March 2015
previous names
N/A
accountant
-
auditor
-
address
unit 7, mulberry place, pinnell road, london, SE9 6AR
Bank
-
Legal Advisor
-
intensive care medicine limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to intensive care medicine limited.
intensive care medicine limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INTENSIVE CARE MEDICINE LIMITED. This can take several minutes, an email will notify you when this has completed.
intensive care medicine limited Companies House Filings - See Documents
| date | description | view/download |
|---|
